Home > Boards > US Listed > Biotechs > Anavex Life Sciences Corp (AVXL)

Is this consortium Missling’s doing? I’m wondering who

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
nidan7500 Member Profile
 
Followed By 19
Posts 4,962
Boards Moderated 0
Alias Born 09/21/16
160x600 placeholder
Anavex Life Sciences Announces Publication of Foundational Data for ANAVEX®2-73 (blarcamesine) in Multiple Sclerosis (MS) GlobeNewswire Inc. - 2/24/2020 7:00:10 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 2/20/2020 4:32:14 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 4:38:56 PM
PURA ALERT - MACD Cross Pushing $0.039 50 Day MA With $0.35 Analyst TGT Recommendation InvestorsHub NewsWire - 2/10/2020 12:50:46 PM
PURA BUY Recommendation at $0.03 Issued By AmericanBulls InvestorsHub NewsWire - 2/7/2020 10:33:33 AM
Anavex Life Sciences Reports Fiscal 2020 First Quarter Financial Results and Provides Clinical Study Updates GlobeNewswire Inc. - 2/6/2020 7:00:10 AM
Anavex Life Sciences to Present and Participate in a Panel at the 2020 BIO CEO & Investor Conference GlobeNewswire Inc. - 2/4/2020 7:00:10 AM
Anavex Life Sciences Announces Fast Track Designation Granted by U.S. FDA for ANAVEX®2-73 (blarcamesine) Clinical Developmen... GlobeNewswire Inc. - 2/3/2020 7:00:10 AM
Anavex Life Sciences to Announce Fiscal 2020 First Quarter Financial Results on Thursday, February 6th, 2020 GlobeNewswire Inc. - 1/30/2020 7:00:10 AM
Anavex Life Sciences Announces Achievement of Enrollment Target for the ANAVEX®2-73 (blarcamesine) Phase 2 Parkinson’s Dis... GlobeNewswire Inc. - 1/27/2020 7:00:10 AM
Anavex Life Sciences Issued New U.S. Patent for ANAVEX®2-73 Treatment of Neurodevelopmental Disorders including Rett Syndrom... GlobeNewswire Inc. - 1/8/2020 7:00:10 AM
Anavex Life Sciences Reports Fiscal Year 2019 Financial Results And Provides Clinical Study Updates GlobeNewswire Inc. - 12/16/2019 7:00:10 AM
Anavex Life Sciences to Announce Fiscal 2019 Year End Financial Results on Monday December 16, 2019 GlobeNewswire Inc. - 12/10/2019 7:00:10 AM
Citation Growth Corp. (OTCQX: CGOTF) Weathering the Cannabis Downturn InvestorsHub NewsWire - 12/9/2019 7:23:11 AM
Citation Growth Corp. (OTCQX: CGOTF) Weathering the Cannabis Downturn InvestorsHub NewsWire - 12/9/2019 6:00:00 AM
Anavex Life Sciences Presents ANAVEX®2-73 (blarcamesine) Data at 12th Clinical Trials on Alzheimer's Disease (CTAD) 2019 Con... GlobeNewswire Inc. - 12/4/2019 7:00:10 AM
Anavex Life Sciences Receives Rare Pediatric Disease Designation from FDA for ANAVEX®2-73 (blarcamesine) for the Treatment o... GlobeNewswire Inc. - 11/14/2019 7:00:00 AM
Anavex Life Sciences Announces Publication of Foundational Data for ANAVEX®2-73 (blarcamesine) in Rett Syndrome GlobeNewswire Inc. - 11/6/2019 7:00:00 AM
Anavex Life Sciences Announces ATTENTION-AD ANAVEX®2-73 Extension Clinical Study in Early Alzheimer’s Disease GlobeNewswire Inc. - 10/9/2019 7:00:00 AM
Anavex Life Sciences Issued New U.S. Patent for Composition of Matter Covering ANAVEX®2-73 for the Treatment of Alzheimer’... GlobeNewswire Inc. - 10/2/2019 7:00:00 AM
Anavex Life Sciences Presented at the 6th Annual European Rett Syndrome Conference Preliminary Clinical Efficacy Data from th... GlobeNewswire Inc. - 9/27/2019 3:00:00 AM
Anavex Life Sciences to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference GlobeNewswire Inc. - 9/26/2019 7:00:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/23/2019 6:35:19 AM
Anavex Life Sciences to Present at the Ladenburg Thalmann 2019 Healthcare Conference GlobeNewswire Inc. - 9/18/2019 7:00:00 AM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 9/17/2019 5:16:10 PM
nidan7500   Saturday, 07/27/19 03:10:46 PM
Re: Jonjones325 post# 203554
Post # of 238730 
Quote:
Is this consortium Missling’s doing? I’m wondering who led this initiative to begin. Wondering if the members were hand selected or was it open. Interesting.



Cannot say where it started but my guess is Dr.M. was involved w/initial strategic initiative. I have been involved myself in some of this and can say it is usually fitting pegs in holes based on strengths and perceived needs. The patent app w/Cognision started 2 years ago. We know Cognision was already in ERP-AI bus but not sure how big they were.

The needs for growth and rapid expansion cannot be handled by a company the size of AVXL. IMO, Dr.M. quickly assembled key known resources and explained his capabilities and the plans/needs. That took at least a year and it would have been pretty much full time effort. I also think that HH went to the Elasai corp. office to make sure all the pieces were fitting and he needed to do that from there inside spot, as a cultural thing. This is just too massive to be done by the old corp. structure. They must all act as one organism. They all had to think and act on a level far above current organizational thinking. That is how big this is, IMO and little Anavex is the critical element. W/O them none of this makes any sense.

You may know that getting linked w/current FDA licensed/registered sites is a big deal (years to do that alone) and one does not want to start that from scratch, you and I would never get our money back as shareholders. IMO, he (M) must have told the chosen few what the CNS Cellular Homeostasis data/story looked like and they jumped on it. None of the consortium makes sense unless you have the SPICE-(see sci fi movie Dunes?)which in this case is A2-73.

So, we have a consortium capable of SW/HW interface with FDA validation systems in place. We have world class operations, sales, purchasing, etc along w/ full scale warehouses, controls, logistics. All the stuff that takes years to get in place. We have WW presence and best of all, seemingly no one O/S caught on. (I do not believe that, which makes the current sp all the more a mystery). Either BP-WS has been completely asleep or they are really a lot dumber and arrogant than anyone could have imagined. So, anyways, they are screwed. IMO, some day soon they will get it, perhaps the peer reviewed paper will be a trigger event.

I have no idea how he did it, but he did, and there is not enough money in the universe to stop them now, IMO. I have a hard time understanding how this got done so quickly. The one real big point is that NONE of it makes any sense unless A2-73 and other such AVXL patented compounds works, which must have been somehow demonstrated. BTW, they will keep this low key for as long as possible but once it does blossom, it will go nuclear. IMO. It is just brilliant planning.
Quote:
ref previous patent app. Inventors:
Cecchi; Marco; (Louisville, KY)
Applicant:
Name
City
State
Country
Type

Anavex Life Sciences Corp.

New York

NY

US

Family ID:
64656515
Appl. No.:
15/622588
Filed:
June 14, 2017



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist